Treponema pallidum, p15, Recombinant
Catalog No : USB-209257
531.05€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Treponema pallidum, p15, Recombinant | ||
|---|---|---|---|
| Catalog No | USB-209257 | ||
| Supplier’s Catalog No | 209257 | ||
| Supplier | US Biologicals | ||
| Source antigen | Recombinant, E. coli | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | |||
| Storage | 4°C Do Not Freeze | ||
|---|---|---|---|
| Other names | |||
| Grade | Highly Purified | ||
| Purity | ~95% (10% PAGE, coomassie staining) | ||
| Form | Supplied as a liquid in 20mM Tris-HCl, pH 8, 10mM B-ME, 8M urea. | ||
| Reactivity life | 12 months | ||
| Note | For reserch purpose only | ||
| Purity | ~95% (10% PAGE, coomassie staining) | ||
| Description | Treponema pallidum is a gram-negative spirochaete bacterium and is considered to be metabolically crippled. There are at least four known subspecies: T. pallidum pallidum, T. pallidum pertenue, T. pallidum carateum and T. pallidum endemicum. The helical structure of T. pallidum pallidum allows it to move in a corkscrew motion through viscous mediums such as mucus. Treponema pallidum sub sp. pallidum has one of the smallest bacterial genomes at 1.14 million base pairs (Mb) and has limited metabolic capabilities, reflecting its adaptation through genome reduction to the rich environment of mammalian tissue. Source: Recombinant protein corresponding to T. Pallidum p15 immunodominant regions, contains beta-galactosidase (~114kD) fused at N-terminus, expressed in E. coli. Specificity: Immunoreactive with sera of T. Pallidum infected individuals. Applications: Suitable for use in ELISA, Western Blot and as an Antigen for the detection of T. Pallidum with minimal specificity problems. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C. For long-term storage, aliquot and store at 4°C. Do not freeze. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer. | ||
Product Details
© 2020 Imugex All Rights Reserved